JP2023540259A5 - - Google Patents
Info
- Publication number
- JP2023540259A5 JP2023540259A5 JP2023513877A JP2023513877A JP2023540259A5 JP 2023540259 A5 JP2023540259 A5 JP 2023540259A5 JP 2023513877 A JP2023513877 A JP 2023513877A JP 2023513877 A JP2023513877 A JP 2023513877A JP 2023540259 A5 JP2023540259 A5 JP 2023540259A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- alkyl
- substituted
- pharmaceutical composition
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020903051 | 2020-08-26 | ||
| AU2020903051A AU2020903051A0 (en) | 2020-08-26 | Compounds, compositions and uses thereof | |
| PCT/AU2021/050978 WO2022040741A1 (en) | 2020-08-26 | 2021-08-25 | Glucosidase inhibitors for the treatment and prevention of pulmonary infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540259A JP2023540259A (ja) | 2023-09-22 |
| JP2023540259A5 true JP2023540259A5 (cg-RX-API-DMAC7.html) | 2024-08-14 |
Family
ID=80352192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513877A Pending JP2023540259A (ja) | 2020-08-26 | 2021-08-25 | 肺感染症の治療および予防用のグルコシダーゼ阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240016786A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4203954A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023540259A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116419754A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021332085B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022040741A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202100027464A1 (it) * | 2021-10-26 | 2023-04-26 | Univ Degli Studi Di Camerino | Composizione comprendente iminozuccheri e/o anisodamina per il trattamento di infezioni virali |
| US12569473B2 (en) * | 2022-07-05 | 2026-03-10 | 60 Degrees Pharmaceuticals, Inc. | Methods to treat respiratory infection utilizing castanospermine analogs |
| CN119841765B (zh) * | 2025-01-09 | 2025-10-10 | 中南大学 | Dnj衍生物、药物组合物及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1876095A (en) * | 1994-02-25 | 1995-09-11 | G.D. Searle & Co. | Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
| GB0116643D0 (en) * | 2001-07-09 | 2001-08-29 | Virogen Ltd | Antiviral compounds |
| FR2861991B1 (fr) * | 2003-11-07 | 2008-01-18 | Centre Nat Rech Scient | Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| WO2011095772A2 (en) * | 2010-02-04 | 2011-08-11 | Summit Corporation Plc | Novel iminosugar therapeutics |
| RS58456B1 (sr) * | 2011-08-01 | 2019-04-30 | Univ Monash | Postupak i formulacije za inhalaciju |
| US10328061B2 (en) * | 2016-05-02 | 2019-06-25 | Florida State University Research Foundation, Inc. | Treatment of Zika virus infections using alpha-glucosidase inhibitors |
| EP3934688A4 (en) * | 2019-03-08 | 2022-12-21 | University of Virginia Patent Foundation | COMPOSITIONS AND METHODS FOR MODULATION OF VIRAL INFECTION THROUGH REGULATION OF GLUCOSYLCERAMIDS |
| EP4106752A4 (en) * | 2020-02-21 | 2024-03-20 | Florida State University Research Foundation, Inc. | TREATMENT OF HUMAN CORONAVIRUS INFECTIONS USING ALPHA-GLUCOSIDASE-GLYCOPROTEIN PROCESSING INHIBITORS |
| US10980756B1 (en) * | 2020-03-16 | 2021-04-20 | First Wave Bio, Inc. | Methods of treatment |
| CN113425720A (zh) * | 2020-04-03 | 2021-09-24 | 深圳前海诺贝尔奖科学家技术转移转化有限公司 | 亚胺糖化合物在制备抗SARS-CoV-2病毒的药物中的用途 |
| US20230270826A1 (en) * | 2020-07-30 | 2023-08-31 | Delta 4 Gmbh | Antiviral use of liraglutide and gefitinib |
-
2021
- 2021-08-25 CN CN202180072511.2A patent/CN116419754A/zh active Pending
- 2021-08-25 AU AU2021332085A patent/AU2021332085B2/en active Active
- 2021-08-25 JP JP2023513877A patent/JP2023540259A/ja active Pending
- 2021-08-25 US US18/022,840 patent/US20240016786A1/en active Pending
- 2021-08-25 WO PCT/AU2021/050978 patent/WO2022040741A1/en not_active Ceased
- 2021-08-25 EP EP21859409.1A patent/EP4203954A4/en active Pending